Suppr超能文献

循环细胞游离 DNA 水平与院外心脏骤停患者复苏后存活率相关。

Circulating cell-free DNA levels correlate with postresuscitation survival rates in out-of-hospital cardiac arrest patients.

机构信息

Department of Emergency Medicine, National Taiwan University Hospital, National Taiwan University Medical College, Taipei, Taiwan.

出版信息

Resuscitation. 2012 Feb;83(2):213-8. doi: 10.1016/j.resuscitation.2011.07.039. Epub 2011 Aug 22.

Abstract

Early prediction of prognosis is helpful in cardiac arrest patients. Plasma cell-free DNA, which increases rapidly after cell death, is a novel biomarker for the prognosis of critical ill patients. Changes in the plasma cell-free DNA level and its role for the early prognosis of cardiac arrest patients remain unclear. We prospectively enrolled adult out-of-hospital cardiac arrest (OHCA) patients with sustained return of spontaneous circulation. The resuscitation variables were recorded following the Utstein recommendation. The plasma cell-free DNA concentration was determined by quantitative real-time polymerase chain reaction assay of β-globin gene. A total of 42 patients were enrolled for the study. The plasma cell-free DNA level within 2h after cardiac arrest was higher in the non-survival group than the survival-to-discharge group (median level 1659.9 g.e./mL vs. 1121.6g.e./mL, p=0.003 by non-parametric test). The plasma cell-free DNA level at 72 h became no difference between these two groups. The optimal cutoff value of plasma cell-free DNA for predicting survival-to-discharge was 1,170 g.e./mL by ROC curve analysis (area under curve 0.752, p=0.010). A plasma cell-free DNA level higher than 1,170 g.e./mL and was an independent predictor for in-hospital mortality by multiple logistic regression analysis (adjusted odds ratio of 12.35, p=0.023) and was also associated with higher 90 day mortality (p=0.021 by log-rank test). In conclusion, the plasma cell-free DNA level increases during the early post-cardiac arrest phase and can be an early prognostic factor for OHCA patients.

摘要

早期预测预后有助于心脏骤停患者。细胞死亡后迅速增加的无细胞血浆 DNA 是危重病患者预后的新型生物标志物。无细胞血浆 DNA 水平的变化及其对心脏骤停患者早期预后的作用尚不清楚。我们前瞻性纳入了伴有持续自主循环恢复的成年院外心脏骤停(OHCA)患者。复苏变量按照 Utstein 推荐进行记录。通过β-球蛋白基因的定量实时聚合酶链反应分析测定无细胞血浆 DNA 浓度。共有 42 例患者入组研究。心脏骤停后 2 小时内,非存活组的无细胞血浆 DNA 水平高于存活至出院组(中位数水平 1659.9 g.e./mL 比 1121.6 g.e./mL,非参数检验 p=0.003)。72 小时时,两组间无细胞血浆 DNA 水平无差异。通过 ROC 曲线分析,预测存活至出院的无细胞血浆 DNA 的最佳截断值为 1170 g.e./mL(曲线下面积 0.752,p=0.010)。多元逻辑回归分析显示,无细胞血浆 DNA 水平高于 1170 g.e./mL 是院内死亡率的独立预测因子(调整优势比 12.35,p=0.023),并且与 90 天死亡率较高相关(log-rank 检验 p=0.021)。总之,无细胞血浆 DNA 水平在心脏骤停后早期阶段增加,可能是 OHCA 患者的早期预后因素。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验